[1] 胡付品,郭燕,朱德妹,等.2020年CHINET中国细菌耐药监测[J].中国感染与化疗杂志,2021,21(4):377-387. DOI:10.16718/j.1009-7708.2021.04.001.
[2] Nordmann P, Naas T, Poirel L. Global spread of Carbapenemase-producing Enterobacteriaceae[J]. Emerg Infect Dis, 2011, 17(10):1791-1798. DOI: 10.3201/eid1710.110655.
[3] Lopes E, Saavedra MJ, Costa E, et al. Epidemiology of carbapenemase-producing Klebsiella pneumoniae in northern Portugal: predominance of KPC-2 and OXA-48[J]. J Glob Antimicrob Resist, 2020, 22:349-353. DOI: 10.1016/j.jgar.2020.04.007.
[4] 杨程茹,王英,李莹,等.重症监护病房耐碳青霉烯类肺炎克雷伯菌分子流行病学研究[J].中国感染控制杂志,2022,21(3):209-216.
[5] 黄声雷,周春妹,曹锦楠,等.两种表型方法检测产碳青霉烯酶肠杆菌目细菌基因型别的应用价值[J].中华医院感染学杂志,2022,32(5):669-673. DOI:10.11816/cn.ni.2022- 212008.
[6] 王育瑛.产KPC型碳青霉烯酶大肠埃希菌分子流行病学及耐药传播机制研究[D]. 杭州:浙江大学,2015.
[7] 冯雅君,沈萍,杜小幸,等.产碳青霉烯酶KPC-2肺炎克雷伯菌局部流行[J].浙江医学,2008,30(9):923-925,930. DOI:10.3969/j.issn.1006-2785.2008.09.003.
[8] 齐艳.产KPC型碳青霉烯酶肺炎克雷伯菌分子分型及传播机制研究[D]. 杭州:浙江大学,2012.
[9] 安军,蔡挺,张顺,等.大肠埃希菌与肺炎克雷伯菌产碳青霉烯酶的表型检测及耐药分析[J].中华医院感染学杂志,2011,21(21):4423-4425.
[10] Wei ZQ, Du XX, Yu YS, et al. Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China[J]. Antimicrob Agents Chemother, 2007, 51(2):763-765. DOI: 10.1128/AAC.01053-06.
[11] 胡咏梅,邹明祥,李军,等.同一患者不同部位分离耐碳青霉烯类肺炎克雷伯菌耐药机制研究及同源性分析[J].临床检验杂志,2017,35(7):511-513,517. DOI:10.13602/j.cnki.jcls.2017.07.08.
[12] 豆清娅,邹明祥,李春辉,等.耐亚胺培南肺炎克雷伯菌的耐药机制研究[J].中华医院感染学杂志,2016,26(13):2906-2909. DOI:10.11816/cn.ni.2016-152360.
[13] 解春宝,喻华,肖代雯,等.一株对3种碳青霉烯类抗菌药物均耐药的肺炎克雷伯菌耐药机制研究[J].检验医学,2014(4):369-374. DOI:10.3969/j.issn.1673-8640.2014. 04.016.
[14] Shen P, Wei Z, Jiang Y, et al. Novel genetic environment of the carbapenem-hydrolyzing beta-lactamase KPC-2 among Enterobacteriaceae in China[J]. Antimicrob Agents Chemother, 2009, 53(10):4333-4338. DOI: 10.1128/AAC.00260-09.
[15] 王厚照,张玲,许树根.医院中心实验室建设指南[M]. 厦门:厦门大学出版社,2016.
[16] Hunter SB, Vauterin P, Lambert-Fair MA, et al. Establishment of a universal size standard strain for use with the PulseNet standardized pulsed-field gel electrophoresis protocols: converting the national databases to the new size standard[J]. J Clin Microbiol, 2005, 43(3):1045-1050. DOI: 10.1128/JCM.43.3.1045- 1050.2005.
[17] Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing[J]. J Clin Microbiol, 1995, 33(9):2233-2239. DOI: 10.1128/jcm.33.9.2233-2239.1995.
[18] 何红,黄紫嫣,陶晓燕,等.耐碳青霉烯类肺炎克雷伯菌产酶耐药机制及同源性分析[J].中华医院感染学杂志,2021,31(3):326-331. DOI:10.11816/cn.ni.2021-206586.
[19] 郑恬,徐修礼,陈潇.肠杆菌科细菌耐药性及其耐碳青霉烯类菌株分布特点[J].中国感染控制杂志,2017,16(2):121-125. DOI:10.3969/j.issn.1671-9638.2017.02.005.
[20] Hamrick JC, Docquier JD, Uehara T, et al. VNRX-5133 (Taniborbactam), a broad-spectrum inhibitor of serine- and metallo-β-lactamases, restores activity of cefepime in Enterobacterales and Pseudomonas aeruginosa[J]. Antimicrob Agents Chemother, 2020, 64(3):e01963-19. DOI: 10.1128/AAC.01963-19.
[21] Munoz-Price LS, Poirel L, Bonomo RA, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases[J]. Lancet Infect Dis, 2013, 13(9):785-796. DOI: 10.1016/S1473-3099(13)70190-7.
[22] 王晓泉. 不同来源多重耐药性沙门氏菌分离株的耐药机制和脉冲场凝胶电泳分析[D]. 扬州:扬州大学,2007.
[23] 刘春红,薛卫强.院内获得性肺炎多重耐药菌感染的流行特征及耐药情况分析[J].国际医药卫生导报,2019,25(4):585-589. DOI:10.3760/cma.j.issn.1007-1245.2019. 04.026.
|